These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 34526842)
1. Cognitive Impairment in Neuromyelitis Optica. Yabalak A; Altunrende B; Demir GA Noro Psikiyatr Ars; 2021; 58(3):200-205. PubMed ID: 34526842 [TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment in Chinese neuromyelitis optica. Zhang N; Li YJ; Fu Y; Shao JH; Luo LL; Yang L; Shi FD; Liu Y Mult Scler; 2015 Dec; 21(14):1839-46. PubMed ID: 25828756 [TBL] [Abstract][Full Text] [Related]
4. The association between body mass index, demographic and clinical characteristics with cognitive performance in patients with neuromyelitis optica spectrum disorder. Rezaeimanesh N; Saeedi R; Sahraian MA; Ghadiri F; Naser Moghadasi A Curr J Neurol; 2022 Apr; 21(2):74-82. PubMed ID: 38011484 [No Abstract] [Full Text] [Related]
5. [Anxiety and Depression in Patients with Neuromyelitis Optica]. Miao XH; Shi ZY; Chen HX; Zhou HY; Yang R Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 48(6):900-904. PubMed ID: 29260529 [TBL] [Abstract][Full Text] [Related]
6. Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis. Vanotti S; Cores EV; Eizaguirre B; Melamud L; Rey R; Villa A Arq Neuropsiquiatr; 2013 Jun; 71(6):357-61. PubMed ID: 23828523 [TBL] [Abstract][Full Text] [Related]
8. Cognitive and psychiatric comorbidities in neuromyelitis optica. Moore P; Methley A; Pollard C; Mutch K; Hamid S; Elsone L; Jacob A J Neurol Sci; 2016 Jan; 360():4-9. PubMed ID: 26723962 [TBL] [Abstract][Full Text] [Related]
9. Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis. Niino M; Mifune N; Kohriyama T; Mori M; Ohashi T; Kawachi I; Shimizu Y; Fukaura H; Nakashima I; Kusunoki S; Miyamoto K; Yoshida K; Kanda T; Nomura K; Yamamura T; Yoshii F; Kira J; Nakane S; Yokoyama K; Matsui M; Miyazaki Y; Kikuchi S BMC Neurol; 2014 Jan; 14():3. PubMed ID: 24393373 [TBL] [Abstract][Full Text] [Related]
10. MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke. Pendlebury ST; Mariz J; Bull L; Mehta Z; Rothwell PM Stroke; 2012 Feb; 43(2):464-9. PubMed ID: 22156700 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of a brief electronic screening test for cognitive impairment in multiple sclerosis (SCI-MS Test). Meca-Lallana JE; Prieto-González JM; Jimenez-Veiga J; Carreón-Guarnizo E; Jiménez-Martín I; Hernández-Clares R; Sistiaga-Berrondo A; Carles-Dies R; García-Molina E; Cerdán-Sánchez M; Costa-Arpín E; Croitoru I; Castillo-Triviño T; Iniesta-Martinez F; García-Pérez E; Olascoaga-Urtaza J Mult Scler Relat Disord; 2019 Feb; 28():50-56. PubMed ID: 30553169 [TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment and whole brain diffusion in patients with neuromyelitis optica after acute relapse. He D; Wu Q; Chen X; Zhao D; Gong Q; Zhou H Brain Cogn; 2011 Oct; 77(1):80-8. PubMed ID: 21723024 [TBL] [Abstract][Full Text] [Related]
13. Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features. Altintas A; Karabudak R; Balci BP; Terzi M; Soysal A; Saip S; Tuncer Kurne A; Uygunoglu U; Nalbantoglu M; Gozubatik Celik G; Isik N; Celik Y; Gokcay F; Duman T; Boz C; Yucesan C; Mangan MS; Celebisoy N; Diker S; Colpak Isikay I; Kansu T; Siva A Neurologist; 2015 Oct; 20(4):61-6. PubMed ID: 26468870 [TBL] [Abstract][Full Text] [Related]
15. Frequency of cognitive impairment in patients with neuromyelitis optica spectrum disorder in Mexico. Valdivia-Tangarife ER; Cortés-Enríquez F; Morlett-Paredes A; Villaseñor-Cabrera T; Gámez-Nava JI; Mireles-Ramírez MA; González-López L; Macías-Islas MÁ Mult Scler J Exp Transl Clin; 2024; 10(1):20552173241231678. PubMed ID: 38410681 [TBL] [Abstract][Full Text] [Related]
16. Changes in mitochondrial function in patients with neuromyelitis optica; correlations with motor and cognitive disabilities. Foolad F; Khodagholi F; Nabavi SM; Javan M PLoS One; 2020; 15(3):e0230691. PubMed ID: 32214385 [TBL] [Abstract][Full Text] [Related]
17. Cognitive function, depression, fatigue, and activities of daily living in patients with neuromyelitis optica after acute relapse. He D; Chen X; Zhao D; Zhou H Int J Neurosci; 2011 Dec; 121(12):677-83. PubMed ID: 21797812 [TBL] [Abstract][Full Text] [Related]
18. Structural MRI substrates of cognitive impairment in neuromyelitis optica. Liu Y; Fu Y; Schoonheim MM; Zhang N; Fan M; Su L; Shen Y; Yan Y; Yang L; Wang Q; Zhang N; Yu C; Barkhof F; Shi FD Neurology; 2015 Oct; 85(17):1491-9. PubMed ID: 26423432 [TBL] [Abstract][Full Text] [Related]
20. Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica. Yang T; Wang S; Zheng Q; Wang L; Li Q; Wei M; Du Z; Fan Y BMC Neurol; 2016 Jul; 16():96. PubMed ID: 27401736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]